Autologous stem cell transplantation for advanced acute myeloid leukemia

被引:0
作者
CA Linker
LE Damon
CA Ries
WA Navarro
D Case
JL Wolf
机构
[1] University of California,
[2] Maine Medical Center,undefined
[3] Alta Bates Medical Center,undefined
来源
Bone Marrow Transplantation | 2002年 / 29卷
关键词
autologous transplantation; acute myeloid leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
We studied the efficacy of a two-step approach to autologous stem cell transplantation for patients with advanced acute myeloid leukemia. Step 1 consisted of consolidation chemotherapy using cytarabine 2000 mg/m2 twice daily for 4 days plus etoposide 40 mg/kg by continuous infusion over the same 4 days. Peripheral blood stem cells were collected under granulocyte colony-stimulating factor (G-CSF) stimulation during recovery from this chemotherapy. Step 2, autologous stem cell transplantation, utilized the preparative regimen of oral busulfan 16 mg/kg followed by etoposide 60 mg/kg i.v. During step 1, there were no treatment-related deaths among 28 patients, but two patients did not proceed to transplantation because of failure of mobilization. A median CD34+ dose (×106/kg) of 13.6 was collected. Of 26 patients undergoing autologous transplant, there was one treatment-related death and 12 relapses. With a median follow-up of 5.4 years, 5 year event-free survival (EFS) of all patients entered is 54%. The most important prognostic factor was cytogenetic changes. All seven patients with t(15,17) remained in long-term remission whereas EFS for other patients was 38%. We conclude that this two-step approach to autologous transplantation produces excellent stem cell yields, allows a high percentage of patients to receive the intended therapy, and provides effective treatment.
引用
收藏
页码:297 / 301
页数:4
相关论文
共 48 条
[1]  
Gorin NC(1998)Autologous stem cell transplantation in acute mye-locytic leukemia Blood 92 1073-1090
[2]  
Linker CA(2000)Autologous stem cell transplantation for acute myeloid leukemia in first remission Biol Blood Marrow Transplant 6 50-57
[3]  
Ries CA(1998)Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxy cyclophosphamide purged bone marrow and the bulsulfan etoposide preparative regimen: a follow-up report Bone Marrow Transplant 22 865-872
[4]  
Damon LE(1997)Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pre-transplant minimal residual disease assessment by reverse transcription polymerase chain reaction of the PMLRAR alpha fusion gene Blood 90 131-1325
[5]  
Sayre P(2000)Stem cell transplantation for acute promyelocytic leukemia in the ATRA era: a survey of the European blood and marrow transplantation group Blood 96 522a-698
[6]  
Linker CA(1996)BAVC regimen: an autograft for acute myelogeneous leukemia in second complete remission Bone Marrow Transplant 18 693-117
[7]  
Ries CA(1996)Retrospective evaluation of autologous bone marrow transplantation Bone Marrow Transplant 18 111-2216
[8]  
Damon LE(1996) allogeneic bone marrow transplantation from an HLA-identical, related donor in acute myelocytic leukemia: a study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) J Clin Oncol 14 2206-357
[9]  
Rugo HS(1998) purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogeneous leukemia in first complete remission Blood 92 (Suppl. 1) 294a-1282
[10]  
Meloni G(1997)Autologous bone marrow transplant for acute myelogeneous leukemia in second or subsequent remission Blood 90 3853-472